久久久噜噜噜久久精品一区二区,日韩中文字幕在线视频线路一,亚洲国产高清久久久精品,TokyoKoT大交乱无码,91精品一区二区在线观看

Through this platform, we facilitate the discovery, and optimization and  pre-clinical evaluation of drug candidates, as well as the advancement of clinical development for investigational drugs.

Leveraging  our insights into inflammatory responses and immune regulation, our innovative drug pipeline is focused on investigational therapies for indications with significant unmet medical needs and substantial global market potential. The pipeline includes one potential first-in-class oncology drug candidate and three additional preclinical-stage innovative candidates for the treatment of oncology, ophthalmology and respiratory diseases.

• Tumor Immunotherapy
• Ophthalmology
• Pulmonary Fibrosis
• CNS
• Self-disease treatment